Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease that affects motor neurons, leading to ...

AUT00201, an oral small molecule, reduced the loss of motor neurons and eased motor symptoms in a mouse model of ALS, a study ...

Salym Liufau was at a family birthday party in 2022 when she squatted to pick up her kids, a motion she’d done a million ...

Cedars-Sinai has created a lifelike model of the mysterious and fatal disease that could help identify a cause of the illness as well as effective treatments.

Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis NEJM DOI: 10.1056/NEJMoa1916945. ALS Drug Study Signals Progress Toward Treatment for Deadly Disease Wall Street Journal.

CB03-154 is a newer ALS therapy that's designed to open nerve cells' KCNQ2 and KCNQ3 potassium channels without affecting ...

The ALS market is witnessing robust growth driven by increased disease awareness, advancements in genetic research, and an expanding pipeline of ther ...

Familial amyotrophic lateral sclerosis (ALS) is an uncommon form of ALS that occurs due to an inherited gene. The disease causes motor neurons to die, which can lead to progressive muscle weakness.

The latest disappointment in amyotrophic lateral sclerosis research brought crushing news for patients and physicians, forcing the community to consider just what to do with an approved medicine ...

First Responder Class on Amyotrophic Lateral Sclerosis (ALS) Sept. 28, 2022 This event is designed to help all first responders be better prepared when responding to a call involving someone with ALS ...

A new treatment for amyotrophic lateral sclerosis, or ALS, has been approved by the US Food and Drug Administration. The FDA announced approval of Relyvrio, developed by Amylyx Pharmaceuticals, on ...

Boynton Beach Mayor Ty Penserga proclaimed Sept. 28 as ALS Awareness Day.Amyotrophic lateral sclerosis is a disease that attacks the nervous system, affecting nerve cells in the brain and spinal ...